Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 109 of 151

  1. REGN2176-3

    Regeneron UK Limited

    Neovascular Age-Related Macular Degeneration

    phase 2 small molecule terminated

    1 trial

  2. REGN2477

    Regeneron UK Limited

    Fibrodysplasia Ossificans Progressiva

    phase 2 small molecule completed

    1 trial

  3. REGN2477+REGN1033

    Regeneron UK Limited

    Sporadic Inclusion Body Myositis

    phase 2 small molecule terminated

    1 trial

  4. REGN2810

    Regeneron UK Limited

    Prostate Cancer Metastatic

    phase 2 small molecule active

    1 trial

  5. REGN3500

    Regeneron UK Limited

    Atopic Dermatitis

    phase 2 small molecule terminated

    2 trials

  6. REGN3918

    Regeneron UK Limited

    Paroxysmal Nocturnal Hemoglobinuria (PNH)

    phase 2 small molecule completed

    1 trial

  7. REGN4336

    Regeneron UK Limited

    Metastatic Castration-resistant Prostate Cancer

    phase 2 small molecule active

    1 trial

  8. REGN4461

    Regeneron UK Limited

    Familial Partial Lipodystrophy

    phase 2 small molecule terminated

    1 trial

  9. REGN475

    Regeneron UK Limited

    Sciatica

    phase 2 small molecule completed

    1 trial

  10. REGN475

    Regeneron UK Limited

    Osteoarthritis

    phase 2 mab terminated

    1 trial

  11. REGN475

    Regeneron UK Limited

    Osteoarthritis of the Knee

    phase 2 small molecule completed

    1 trial

  12. REGN475/SAR164877

    Regeneron UK Limited

    Abdominal Pain Upper

    phase 2 small molecule terminated

    1 trial

  13. REGN475/SAR164877

    Regeneron UK Limited

    Back Pain

    phase 2 small molecule terminated

    1 trial

  14. REGN5069

    Regeneron UK Limited

    Osteoarthritis of the Knee

    phase 2 small molecule terminated

    1 trial

  15. REGN5093

    Lacuna Pharma Pty Ltd

    MET-altered non-small cell lung cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  16. REGN5093

    Regeneron UK Limited

    NSCLC

    phase 2 small molecule active

    1 trial

  17. REGN5381

    Regeneron UK Limited

    Heart Failure

    phase 2 small molecule terminated

    2 trials

  18. REGN5381

    Regeneron UK Limited

    Uncontrolled Hypertension

    phase 2 small molecule terminated

    1 trial

  19. REGN5459

    Regeneron UK Limited

    Relapsed Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  20. REGN5668

    Regeneron UK Limited

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  21. REGN5678

    Regeneron UK Limited

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    phase 2 small molecule active

    1 trial

  22. REGN7041

    Regeneron UK Limited

    Active Noninfectious Uveitis Affecting the Posterior Segment

    phase 2 small molecule active

    1 trial

  23. REGN7041

    Lacuna Pharma Pty Ltd

    Noninfectious Uveitis

    phase 2 small molecule active

    1 trial

  24. REGN7075

    Regeneron UK Limited

    Advanced Solid Tumors

    phase 2 small molecule active

    1 trial

  25. REGN7257

    Lacuna Pharma Pty Ltd

    Severe aplastic anemia (SAA)

    phase 2 small molecule active

    1 trial

  26. REGN7508

    Regeneron UK Limited

    Venous Thromboembolism

    phase 2 small molecule completed

    1 trial

  27. REGN7544

    Regeneron UK Limited

    Sepsis-Induced Hypotension

    phase 2 small molecule completed

    1 trial

  28. REGN7544

    Regeneron UK Limited

    Postural Orthostatic Tachycardia Syndrome (POTS)

    phase 2 small molecule active

    1 trial

  29. REGN7544, REGN7544 Matching Placebo

    Lacuna Pharma Pty Ltd

    Sepsis-Induced Hypotension

    phase 2 small molecule active

    1 trial

  30. REGN7999

    Regeneron UK Limited

    Non-Transfusion Dependent Beta-Thalassemia (NTDT)

    phase 2 small molecule active

    1 trial

  31. REGN846

    Regeneron UK Limited

    Pruritus

    phase 2 small molecule terminated

    1 trial

  32. REGN910-3

    Regeneron UK Limited

    Diabetic Macular Edema

    phase 2 small molecule completed

    1 trial

  33. REGN910-3

    Regeneron UK Limited

    Neovascular Age-Related Macular Degeneration

    phase 2 small molecule completed

    2 trials

  34. REGN9933

    Regeneron UK Limited

    Venous Thromboembolism

    phase 2 small molecule completed

    2 trials

  35. REGV131

    Regeneron UK Limited

    Hemophilia B

    phase 2 small molecule active

    1 trial

  36. REGV131, LNP1265

    Lacuna Pharma Pty Ltd

    Hemophilia B

    phase 2 small molecule active

    1 trial

  37. REKOVELLE for Idiopathic male infertility (in…

    Ferring Pharmaceuticals

    Idiopathic male infertility (including oligoasthenozoospermia).

    phase 2 small molecule active

    1 trial

  38. REL-1017

    RELMADA THERAPEUTICS, INC.

    Depressive Disorder, Major

    phase 2 small molecule completed

    1 trial

  39. RELUGOLIX

    Fondazione Telethon ETS

    Intermediate risk prostate cancer

    phase 2 small molecule active

    1 trial

  40. REO 029

    ONCOLYTICS BIOTECH INC

    Patients with advanced or metastatic gastrointestinal (GI) tumors.

    phase 2 small molecule active

    1 trial

  41. REOLYSIN

    ONCOLYTICS BIOTECH INC

    Metastatic Pancreatic Adenocarcinoma

    phase 2 mab completed

    1 trial

  42. REOLYSIN

    ONCOLYTICS BIOTECH INC

    Metastatic or Recurrent Squamous Cell Carcinoma of the Lung

    phase 2 mab completed

    1 trial

  43. REOLYSIN

    ONCOLYTICS BIOTECH INC

    Metastatic Melanoma

    phase 2 mab completed

    1 trial

  44. REOLYSIN®

    ONCOLYTICS BIOTECH INC

    Carcinoma, Non-small Cell Lung

    phase 2 mab completed

    1 trial

  45. REOLYSIN®

    ONCOLYTICS BIOTECH INC

    Osteosarcoma

    phase 2 mab completed

    1 trial

  46. REPRAB - MITO 36

    Fondazione Telethon ETS

    recurrent ovarian cancer

    phase 2 small molecule active

    1 trial

  47. REPRINT

    Fondazione Telethon ETS

    Collecting Duct Carcinoma, Medullary Renal cell Carcinoma

    phase 2 small molecule active

    1 trial

  48. RESCUE-HUB

    Istituto Gentili S.r.l.

    unresectable hepatocellular carcinoma (HCC)

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.